Skip to main content
. 2018 Jun 19;6(2):69. doi: 10.3390/healthcare6020069

Figure 1.

Figure 1

Anti-Borrelia immunoblot tests. Representative reactivity of the WB/VlsE IgG and WB IgM after incubation with sera from patients with late Lyme disease (IgG) and erythema migrans (IgM), respectively (left two panels). Schematic representation of antigens used in the line blot assays EUROLINE-RN-AT IgG and EUROLINE-RN-AT IgM (right two panels).